Michelle is one of the group leaders of the validation systems core at Cell Signaling Technology (CST), where she is responsible for curating and maintaining the standard inventory of cell lines, lysates, and fixed cell preps for use by the CST R&D teams. With a focus on maintaining healthy, uncontaminated samples, Michelle and her team routinely perform cell and tissue lysate production, transfection of over-expression vectors and siRNA, and formaldehyde and methanol fixation. Her group strives to maintain a 100% in-stock rate with no internal backorders, ensuring that quality sample materials are always available for ongoing research needs.
